Fayez Sarofim & Co
HUM icon

Fayez Sarofim & Co’s Humana HUM Stock Holding History

Fayez Sarofim & Co’s Portfolio HUM Stock Details HUM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,800
Closed -$457K – 317
2024
Q4 		$457K Hold
1,800
– – ﹤0.01% 238
2024
Q3 		$570K Hold
1,800
– – ﹤0.01% 208
2024
Q2 		$673K Hold
1,800
– – ﹤0.01% 195
2024
Q1 		$624K Hold
1,800
– – ﹤0.01% 205
2023
Q4 		$667K Buy
1,800
+700
+64% +$345K ﹤0.01% 191
2023
Q3 		$535K Hold
1,100
– – ﹤0.01% 207
2023
Q2 		$492K Buy
1,100
+300
+38% +$151K ﹤0.01% 210
2023
Q1 		$388K Buy
+800
New +$395K ﹤0.01% 231

Other funds holding HUM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $32.7B AUM 17.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fayez Sarofim & Co's HUM Position: Q1 2025 in Review

Fayez Sarofim & Co sold out of Humana (HUM) in Q1 2025, closing a stake of 1,800 shares — an estimated $457K sold.

Fayez Sarofim & Co first reported a position in HUM in Q1 2023 and held it in 8 quarters. The position peaked at $673K in Q2 2024. 902 funds tracked by Wall St. Rank hold HUM as of Q1 2025.

  • Fayez Sarofim & Co reported no remaining Humana position as of Q1 2025 after selling out during the quarter.
  • Fayez Sarofim & Co sold 1,800 Humana shares in Q1 2025, an estimated $457K.
  • Fayez Sarofim & Co first reported a position in Humana in Q1 2023 and held it in 8 quarters.
  • Fayez Sarofim & Co's Humana position peaked at $673K in Q2 2024.
  • 902 funds tracked by Wall St. Rank held Humana as of Q1 2025.

Based on Fayez Sarofim & Co's 13F filing for Q1 2025, filed 12 May 2025.